These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 35066497)

  • 1. Is Serotonin the Missing Link between COVID-19 Course of Severity in Patients with Diabetes and Obesity?
    Santos AP; Couto CF; Pereira SS; Monteiro MP
    Neuroendocrinology; 2022; 112(11):1039-1045. PubMed ID: 35066497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Centrality of Obesity in the Course of Severe COVID-19.
    Liu D; Zhang T; Wang Y; Xia L
    Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodontitis and coronavirus disease 2019.
    Tamimi F; Altigani S; Sanz M
    Periodontol 2000; 2022 Jun; 89(1):207-214. PubMed ID: 35244975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes, obesity and COVID-19: A complex interplay.
    Vas P; Hopkins D; Feher M; Rubino F; B Whyte M
    Diabetes Obes Metab; 2020 Oct; 22(10):1892-1896. PubMed ID: 32627299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
    Colacci A; Bortone G; Maffei G; Marchesi S; Mescoli A; Parmagnani F; Pillo G; Ranzi A; Rotondo F; Serra S; Vaccari M; Zauli Sajani S; Mascolo MG; Jacobs MN
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):169-182. PubMed ID: 33412808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-COVID syndrome, inflammation, and diabetes.
    Rizvi AA; Kathuria A; Al Mahmeed W; Al-Rasadi K; Al-Alawi K; Banach M; Banerjee Y; Ceriello A; Cesur M; Cosentino F; Galia M; Goh SY; Janez A; Kalra S; Kempler P; Lessan N; Lotufo P; Papanas N; Santos RD; Stoian AP; Toth PP; Viswanathan V; Rizzo M;
    J Diabetes Complications; 2022 Nov; 36(11):108336. PubMed ID: 36228563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: Are Non-Communicable Diseases Risk Factors for Its Severity?
    Bello B; Useh U
    Am J Health Promot; 2021 Jun; 35(5):720-729. PubMed ID: 33576237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature.
    Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS
    Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
    Pugliese G; Vitale M; Resi V; Orsi E
    Acta Diabetol; 2020 Nov; 57(11):1275-1285. PubMed ID: 32865671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 and diabetes-Two giants colliding: From pathophysiology to management.
    Pelle MC; Zaffina I; Provenzano M; Moirano G; Arturi F
    Front Endocrinol (Lausanne); 2022; 13():974540. PubMed ID: 36060943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unwinding Link between Coronavirus and Diabetes Patient.
    Bhadauria SS; Malviya R; Sharma PK
    Endocr Metab Immune Disord Drug Targets; 2022; 22(11):1091-1110. PubMed ID: 35352656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity.
    Buscemi S; Corleo D; Randazzo C
    Adv Exp Med Biol; 2021; 1353():115-129. PubMed ID: 35137371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the link between Diabetes mellitus and SARS-CoV-2 infection through differential targeting of microRNAs in the human pancreas.
    Bhavya ; Pathak E; Mishra R
    J Endocrinol Invest; 2022 Mar; 45(3):537-550. PubMed ID: 34669152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity: A Risk Factor for COVID-19.
    Srivastava S; Rathor R; Singh S; Kumar B; Suryakumar G
    Adv Exp Med Biol; 2021; 1352():195-210. PubMed ID: 35132602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
    Jakob CEM; Borgmann S; Duygu F; Behrends U; Hower M; Merle U; Friedrichs A; Tometten L; Hanses F; Jung N; Rieg S; Wille K; Grüner B; Klinker H; Gersbacher-Runge N; Hellwig K; Eberwein L; Dolff S; Rauschning D; von Bergwelt-Baildon M; Lanznaster J; Strauß R; Trauth J; de With K; Ruethrich M; Lueck C; Nattermann J; Tscharntke L; Pilgram L; Fuhrmann S; Classen A; Stecher M; Schons M; Spinner C; Vehreschild JJ
    Infection; 2021 Feb; 49(1):63-73. PubMed ID: 33001409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and Cardiovascular Comorbidities.
    Müller-Wieland D; Marx N; Dreher M; Fritzen K; Schnell O
    Exp Clin Endocrinol Diabetes; 2022 Mar; 130(3):178-189. PubMed ID: 33157558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.